197 related articles for article (PubMed ID: 38068712)
1. Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression.
Shen CK; Huang BR; Charoensaensuk V; Yang LY; Tsai CF; Liu YS; Lai SW; Lu DY; Yeh WL; Lin C
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068712
[TBL] [Abstract][Full Text] [Related]
2. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.
Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.
Qiu XY; Hu DX; Chen WQ; Chen RQ; Qian SR; Li CY; Li YJ; Xiong XX; Liu D; Pan F; Yu SB; Chen XQ
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1754-1769. PubMed ID: 29510196
[TBL] [Abstract][Full Text] [Related]
4. MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
Liu YS; Lin HY; Lai SW; Huang CY; Huang BR; Chen PY; Wei KC; Lu DY
Oncogene; 2017 Aug; 36(35):5006-5022. PubMed ID: 28459461
[TBL] [Abstract][Full Text] [Related]
5. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of IL-1β in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1.
Shen CK; Huang BR; Yeh WL; Chen CW; Liu YS; Lai SW; Tseng WP; Lu DY; Tsai CF
Eur J Pharmacol; 2021 Aug; 905():174216. PubMed ID: 34058204
[TBL] [Abstract][Full Text] [Related]
7. Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages.
Liu X; Li Z; Sun J; Zhang Z; Li W
BMC Cancer; 2023 Mar; 23(1):259. PubMed ID: 36941554
[TBL] [Abstract][Full Text] [Related]
8. PD-L1/PD-1 Axis in Glioblastoma Multiforme.
Litak J; Mazurek M; Grochowski C; Kamieniak P; Roliński J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661771
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion.
Zheng Y; Yang W; Aldape K; He J; Lu Z
J Biol Chem; 2013 Nov; 288(44):31488-95. PubMed ID: 24045955
[TBL] [Abstract][Full Text] [Related]
10. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X
Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429
[TBL] [Abstract][Full Text] [Related]
11. Paliperidone Inhibits Glioblastoma Growth in Mouse Brain Tumor Model and Reduces PD-L1 Expression.
Liu YS; Huang BR; Lin CJ; Shen CK; Lai SW; Chen CW; Lin HJ; Lin CH; Hsieh YC; Lu DY
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503167
[TBL] [Abstract][Full Text] [Related]
12. MiR-10b-5p Impairs TET2-Mediated Inhibition of PD-L1 Transcription Thus Promoting Immune Evasion and Tumor Progression in Glioblastoma.
Du W; Chen D; Wei K; Yu D; Gan Z; Xu G; Yao G
Tohoku J Exp Med; 2023 Jul; 260(3):205-214. PubMed ID: 37019647
[TBL] [Abstract][Full Text] [Related]
13. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
[TBL] [Abstract][Full Text] [Related]
14. Rapid tumor recurrence in a novel murine GBM surgical model is associated with Akt/PD-L1/vimentin signaling.
Liu F; Xu XH; Li CY; Zhang TT; Yin SL; Liu GQ; Hu F; Yu SB; Chen XQ
Biochem Biophys Res Commun; 2021 Sep; 569():1-9. PubMed ID: 34216991
[TBL] [Abstract][Full Text] [Related]
15. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.
Yi K; Cui X; Liu X; Wang Y; Zhao J; Yang S; Xu C; Yang E; Xiao M; Hong B; Fang C; Kang C; Tan Y; Wang Q
Front Immunol; 2021; 12():802795. PubMed ID: 35069587
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
Lamano JB; Lamano JB; Li YD; DiDomenico JD; Choy W; Veliceasa D; Oyon DE; Fakurnejad S; Ampie L; Kesavabhotla K; Kaur R; Kaur G; Biyashev D; Unruh DJ; Horbinski CM; James CD; Parsa AT; Bloch O
Clin Cancer Res; 2019 Jun; 25(12):3643-3657. PubMed ID: 30824583
[TBL] [Abstract][Full Text] [Related]
17. Urolithin A Is a Dietary Microbiota-Derived Human Aryl Hydrocarbon Receptor Antagonist.
Muku GE; Murray IA; Espín JC; Perdew GH
Metabolites; 2018 Nov; 8(4):. PubMed ID: 30501068
[TBL] [Abstract][Full Text] [Related]
18. The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma.
Jin UH; Karki K; Cheng Y; Michelhaugh SK; Mittal S; Safe S
J Biol Chem; 2019 Jul; 294(29):11342-11353. PubMed ID: 31171720
[TBL] [Abstract][Full Text] [Related]
19. Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.
Zhang Q; Zhang J; Wang P; Zhu G; Jin G; Liu F
Stem Cell Res Ther; 2022 Jun; 13(1):284. PubMed ID: 35765095
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients.
Liu Y; Carlsson R; Ambjørn M; Hasan M; Badn W; Darabi A; Siesjö P; Issazadeh-Navikas S
J Neurosci; 2013 Aug; 33(35):14231-45. PubMed ID: 23986257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
